Back

Intermittent therapy with levosimendan in patients with advanced heart failure

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Chronic heart failure e-posters Heart Transplantation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Michael Weis

Sister of Mercey Hospital Neuwittelsbach, Munich (Germany)

218 More presentations in this session

Presentation thumbnail
Differences in long-term all-cause and cardiovascular mortality according to heart failure aetiology in ambulatory patients
Doctor G. Spitaleri (Sant Joan Despi (Barcelona), ES)
Abstract Slides
Presentation thumbnail
Comparing the central arterial stiffness indices in the decompensated and compensated states of heart failure: a cohort study
Assistant Professor G. Youssef (Cairo, EG)
Abstract Slides
Presentation thumbnail
Opportunities for clinician education in the pharmacotherapy of stable heart failure
Doctor P. Murray (Toronto, CA)
Abstract Slides
Presentation thumbnail
Systolic blood pressure visit-to-visit variability and clinical outcomes of heart failure with preserved ejection fraction
Doctor Q. Zhang (Tianjin, CN)
Abstract Slides
Presentation thumbnail
The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
Mrs O. Obertynska (Vinnitsa, UA)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Dealing with Heart Failure (again) after Cardiac Transplant
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Hemochromatosis-induced cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources